Introduction
Certain tumors occur more frequently in Human Immunodeficiency Virus (HlV)-infected individuals: since 1985, high-grade non-Hodgkin's Lymphoma has been an AIDS-defining illness [1] . It has been calculated that at least 5%-10% of HIV-infected individuals develop a lymphoma during the course of the infection [2] . Primary central nervous system lymphomas (PCNSL), which in recent decades have also been undergoing an unexplained increase in incidence in the general population [3] , account for up to 25% of all AIDS-associated lymphomas, but early diagnosis of the disease still constitutes a major challenge. Indeed, the imaging characteristic of PCNSL and other mass lesions, of which toxoplasmosis is the one that occurs most frequently in the brain of HIV-positive subjects [4] [5] [6] [7] , overlap to such a degree that it is nearly impossible to distinguish among the lesions on the basis of their appearance on computed tomography (CT) scan or magnetic resonance imaging (MRI) alone [8] . Nevertheless, early discrimination between PCNSL and toxoplasmosis proffers a unique opportunity to alter the natural history of a neoplasm which, if untreated, has a mortality rate of 75% within 45 days [6, 9, 10] .
Only stereotactic brain biopsy can at present be considered a gold standard for diagnosis, but its safety and usefulness are still a matter for debate in this setting. The development of new non-invasive diagnostic tools is thus warranted for identification of PCNSL without delay or risk and to increase the possibility of treatment and improve the survival of patients who would otherwise die in a very short time.
Major benefit could derive from a correlation of morphologic and functional information at the CNS level. Further enhancement of diagnostic accuracy by examination of cerebrospinal fluid (CSF) for the Epstein-Barr virus (EBV) and by nested-polymerase chain reaction (PCR), is considered.
Case history
A 29-year-old male, formerly an intravenous drug user, with advanced HIV infection and a CD4 lymphocyte count of 11 / ul, was admitted to our division in November 1995. Anamnestic diagnosis of cerebral toxoplasmosis occurring two years previously, and successfully treated with pyrimethamine and sulfadiazine, was noted. A diagnosis of recurring cerebral toxoplasmosis was made elsewhere, based on persistent frontal cephalalgy which subsided after osmotic diuretic administration but not after analgesics and/or vasoconstrictors, associated right motor hemisyndrome and both CT and MR evidence of a peripheral contrast-uptaking lesion, spread among the left basal nuclei, with widespread edema. Prior to admission the patient had undergone a 14-day treatment with pyrimethamine and sulfamethoxypirazine, with neither clinical nor radiologic improvement. The patient had marked frontal cephalalgia, which he described as continuous and dull; physical examination revealed significant right-sided hypostenia coupled with impaired function of homolateral facial nerve of central origin. A further CT scan (Figure 1) , performed with delayed-scan technique after injection of 200 ml of Iopromide, showed a 4.5-cm sized lesion, surrounded by widespread vasogenic edema in the left parietal region, with a consequent bulk effect on the left lateral ventricle and Septum Pellucidum. The lesion enhanced peripherally, whereas its core appeared hypodense, due to necrosis. Second-line anti-protozoal therapy with pyrimethamine and clyndamicine plus carbamazepine was delivered after a lumbar puncture, which demonstrated an increased level of proteins, a normal level of glucose and very few cells (2/field). Direct examination, cryptococcal capsular antigen detection, examination for M. tuberculosis and cultures for bacteria and fungi of the CSF proved negative, whereas CSF nested-PCR was found positive for EBV DNA and negative for CMV, JC Virus and M. tuberculosis. Due to the worsening condition of the patient, we felt brain biopsy to be inappropriate, and he was submitted to brain 201-thallium single photon emission computed tomography (201-T1 SPECT) (Figure 2 ), performed through a wide-field gamma camera SP.4 Apex Elscint (Haifa, Israel), equipped with a LEAP collimator. The image acquisition was achieved by a step and shoot technique along 90 frames with angular sampling of 4°, reconstructed and displayed on a 64 x 64 matrix, 30 minutes after IV injection of 111 MBq of 201-T1 chloride. Transaxial reconstruction was prefiltered using a Butterworth filter (cutoff frequency 0.4 cycles/cm; power factor 10). A correction factor of 0.15 was employed for attenuation. Subsequently, coronal, sagittal and oblique views were generated. In these transaxial views, images in which the lesion showed the greatest activity were selected, and a region of interest (ROI) was drawn around the lesion. A similar ROI was drawn in the contralateral hemisphere. The average number of counts per pixel was determined for each ROI as uptake ratio (UR). In our case, the UR was found to be 3 between the lesion and its counterpart in the uninvolved hemisphere. SPECT demonstrated a significant fixation of radiothallium in the left paraventricular region, very close to the homolateral basal nuclei. This finding confirmed the previous radiologic examinations and, coupled with the result of the virological test, led to a presumptive diagnosis of PCNSL. Complete staging (chest X-rays, thoracic, abdominal and pelvic CT scan, bone-marrow examination) revealed no systemic evidence of the presumed lymphoma. Anti-protozoal drugs were immediately withdrawn, and the patient received corticosteroids and regional radiotherapy (RT). A complete course of whole-brain RT (total dose: 44 Gy) was delivered. Progressive and remarkable clinical improvement was recorded, with the almost complete disappearance of neurologic symptoms within 30 days. CT scan, performed at the end of RT delivery, demonstrated a great reduction of the bulk effect and the disappearance of perilesional edema: both the left lateral ventricle and the Septum Pellucidum appeared normal. The frontal horn of the lateral ventricle was mildly enlarged, probably due to the loss of matter consequent to the debulking effect.
Furthermore, a CT scan ( Figure 3 ) performed six months after the RT clearly showed a decrease in the size of the tumor mass and the amount of perilesional edema, with a further re-expansion of the ventricular system. Eight months after RT the patient was still alive and appearently disease-free but died two months later of P. carinii pneumonia, without signs or symptoms of recurring lymphoma. 
Brain biopsy and open questions
Figure i. CT scan performed after RT delivery. There is a remarkable reduction of bulk effect and perilesional edema.
Discussion

Overview and radiological features
Lymphomas represent a major clinical problem in patients with HIV infection: at least 5%-10% of HIVinfected individuals develop a lymphoma during the course of their infection [2] . PCNSL account for up to 25% of all AIDS-associated lymphomas and the diagnosis is currently performed by histological examination or retrospectively on necropsy samples; three-quarters of all PCNSL arise just adjacent to cortical convexities or ventricular surfaces, demonstrating the propensity of this tumor to spread along CSF pathways, as postulated by Fine and Mayer [11] ; there are no significant features with regard to the number and the localization of mass lesions within the brain which help differentiate between toxoplasmosis and PCNSL [8, [12] [13] [14] [15] . Moreover, PCNSL in HIV-1-positive patients is not detected on CT scan in approximately 10% [16, 17] . Though MR1 scans may be a more sensitive technique for detecting multifocal lesions, it remains to be determined whether MRI is more sensitive in revealing tumors in patients with normal CT scans [11] . Furthermore, PCNSL can seldom be differentiated on the basis of their neuroradiological features from either toxoplasmosis, the most common cause of focal central nervous system infection complicating AIDS, or any less common bacterial or fungal abscess and CMV infection [16] . Indeed, toxoplasmosis, PCNSL and occasionally, as recently reported by Mouligner et al., CMV [18] , all present with typical enhancing mass lesions with surrounding edema, on either contrast-enhancing CT or gadolinium-enhanced MR imaging [12] ; MRI reveals no additional specific characteristics that could help make a definitive diagnosis [12] .
The high incidence and treatability of toxoplasmosis has led to the recommendation that brain biopsy be reserved for those patients in whom empiric therapy for toxoplasmosis has failed, or who present with lesions atypical for toxoplasmosis [4, 19, 20] . Brain biopsy is considered the most effective procedure in differentiating brain mass lesions [6, 21, 22] . However, several scientific papers have appeared in the last few years which indicate that there is no substantial agreement about the safety and effectiveness of this procedure [10, 14, 19, 20, [23] [24] [25] . While it is generally accepted that biopsy should be performed only in patients with a high preoperative performance status and an acceptable life expectancy [26] , some authors believe that biopsy is generally safe and reliable [17] . They recommend its use early in the course of the disease, when no response is achieved with appropriate empirical therapy against T. gondii, or immediately in those showing rapid clinical deterioration and in whom neither CT nor MRI has helped define the diagnosis [10, 23] . However, other authors have reported that biopsy produces an increased risk of intracranial bleeding in AIDS patients whose platelet counts and function are depressed. They feel that the indication for surgical intervention must be thoroughly discussed with regard to its advantages, subsequent possible therapeutic approaches and the risk of bleeding, which seems to be higher in HIV-infected than in HIV-seronegative patients with primary brain tumors [20] . Moreover, it is noteworthy that in the series reported by Feiden et al. [20] , all biopsy specimens of HIV-associated PCNSL showed sometimes widespread tumor necroses, precluding an exact histologic lymphoma subclassification [27] . The spontaneous trend to form coagulative necrosis, both in focal toxoplasmosis and HIV-associated PCNSL, can finally make the sampling of a representative biopsy sample and the morphological diagnosis more difficult [20, 24, 28] . Some lesions, in addition, develop during maintenance therapy, as occurred in our case. In this situation, the pathologist will be examining tissue from brain lesions altered by antibiotic and/or dexamethasone medication [28] . As a last resort, patients suspected of having PCNSL should be promptly referred to a neurosurgeon for performance of a stereotactic biopsy for histologic confirmation of the diagnosis. However, this could be complicated, with consequent further delays.
Functional imaging techniques: A promise for the future
Nowadays there is great hope that useful information will be gained from correlating the results of conventional with functional brain imaging. Magnetic resonance spectroscopy (MRS) is a technique for functional imaging that should aid in the differential diagnosis of brain mass lesions [8] . The key to diagnostic accuracy of MRS is the use of a sophisticated mathematical analysis of the pattern of distribution of chemical constituents of different tumors [29, 30] . However, Walot et al. have demonstrated that even on MRS there may be considerable overlap between the spectra of these lesions [8] ; in particular, they observed that lymphomas with central necrosis may have spectra very much like the ones of toxoplasmic lesions. These findings also apply to spinecho proton MR, whose first investigations failed to assess such a specificity [22] .
For the present, 201-T1 single photon emission computed tomography (SPECT) and positron emission tomography (PET) with 18-F fluorodeoxyglucose (FDG), if carefully done, have been shown to distinguish tumor from infection occurring within the brain: lymphoma has been diagnosed with over 90% accuracy using 201-T1 and FDG [15, [31] [32] [33] . Thus, in the area of opportunistic infections and brain tumors, combined morphologic and functional imaging techniques play a crucial role in both detection and the establishment of a firm diagnosis with a view to selecting appropriate treatments. Since delayed treatment of PCNSL may have dire consequences, appropriate treatment is an immediate requirement and differentiation of the two conditions is critical. Although FDG scans are superior to SPECT imaging in resolution and quantification of brain uptake, PET is less readily available and much more expensive than 201-T1. In addition, FDG is taken up by normal tissues as well as viable tumors, which may lower the target/background ratio in PET as compared with SPECT [28] . Thus, it is likely that 201-T1 will remain the most commonly used agent for diagnosing active malignancy in AIDS patients [15] .
201-Tl SPECT
For the above reasons, 201-Tl SPECT is probably the best procedure for functional imaging of brain tumors. 201-Tl has biological properties similar to those of kalium [34] ; the imaging appears to be related to cell growth rate and blood flow [28] . In addition, 201-T1-increased uptake is not related to permeability of the blood-brain barrier in lesions other than tumors, and tumor uptake appears to be unaffected by steroid administration [28, 34] , In contrast, 201-Tl does not appear to accumulate in non-neoplastic lesions such as hematomas, radiation necrosis and infectious processes such as toxoplasmosis [28, 34, 35] . Because of these properties, 201-Tl SPECT is a useful supplement to conventional morphologic techniques and MRI for differentiating between lymphomas and infectious lesions in AIDS patients [36] [37] [38] [39] ; this appears true even when it is the only tool used, especially if a quantitative analysis is performed [15] . Although there are still problems in selection of the best cutoff value for the UR between involved and uninvolved regions of the brain, it now seems reasonable to consider an UR > 2.5 as positive for lymphoma, in accord with reports which have appeared over the past two years [15, [36] [37] [38] .
Cerebrospinalfluid and EBV
Even though a lumbar puncture to obtain CSF for cytological analysis can be safely done, provided the patient does not have increased intracranial pressure or fourth ventricle obstruction, it has been shown that involvement of CSF in PCNSL is seen in fewer than 30% of cases [11] . Thus, cytologic samples from CSF are often not very helpful in diagnosing PCNSL.
A more promising route appears to be the search for EBV genome into CSF. EBV, a B-lymphotropic virus carried latently throughout life by most of the human population after primary infection, is now believed to play a key role in driving malignant B-cell transformation. It appears to have a role in causing lymphoproliferative disorders and immune-compromised hostrelated lymphomas [2] . Recent papers have shown that detection of EBV DNA in CSF results in a 98.5% specificity and a 100% sensitivity in diagnosing AIDSrelated PCNSL, using polymerase chain reaction to demonstrate viral genetic material (EBNA-1 gene) [40, 41] . These findings strongly suggest a use for detection of EBV in CSF as a specific tumor marker. In contrast, CSF Interleukin-10, the production of which is usually associated with the presence of EBV in cells of systemic lymphomas, failed to exhibit any effect as a diagnostic marker for PCNSL in a recent study [41] ,
In retrospective studies, MacMahon et al. and Cinque et al. have also demonstrated a 100% association between EBV and PCNSL through Southern blot hybridization, which made it possible to detect the expression of the short non-protein coding EBV transcripts (EBERs) over tumor cells, extracted through biopsy from, or at necropsy of, patients affected by PCNSL [40, 42] . This significant association between EBERs expression and PCNSL suggests that the pathogenesis of these lymphomas may differ from that of systemic lymphomas, which are associated with EBV in only 30%-50% of the cases [42] .
Conclusions
Imaging requirements in the practice of oncology have multiplied in recent years as diagnosis has become more refined and treatments more closely tailored to the needs and diseases of individual patients [43] . Correlative morphologic and functional imaging, eventually improved by other tools, as in our case, for diagnosis, staging and follow-up of cancer patients, is expected to open new frontiers which appear very promising. These techniques should be directly exploited by oncologists for the detection of tumors whose primary site is unknown, and for assessment of the real stage of a disease by disclosing micrometastases unrevealed by morphologic techniques alone, for differentiation between residual active disease or recurrence and fibrosis. In other words, they should inform the decision of surgeons, oncologists and radiotherapists as to the best therapeutic approach for each patient [13, 43] . It is also expected that in future such collaborative efforts, together with improved skills in any related field of investigation, will lead to the ability to monitor non-invasively the effects of cytotoxic treatments on both tumor cell and normal tissue metabolism, possibly allowing individual tailoring of therapy according to response [13, 43, for review].
Another future scenario will be the availability of antineoplastic drugs (prodrugs, highly toxic metabolic poisons, etc.) bound to radiopharmaceuticals, whose peculiar characteristic is believed to be the almost absolute selectivity of the target: this feature will allow delivery of drugs only to neoplastic cells, sparing normal tissues, and will raise new therapeutic hope for every patient affected by cancer.
In our case, we used the nested-PCR technique on CSF to detect EBV DNA, combined with 201-T1 SPECT to diagnose PCNSL, and preclude the risks related to cerebral stereotactic biopsy. A 14-day specific therapy for toxoplasmosis had been delivered, but the dimensions of the brain mass lesion had nevertheless almost doubled. This finding, together with a concomitant deterioration of the patient's condition, were the rationale for this diagnostic procedure.
In our opinion, even if brain biopsy is considered the most useful diagnostic procedure, it must be said that its disadvantages need to be taken into consideration. We would therefore suggest that a new intermediate step in the diagnostic algorithm of contrast-enhancing brain mass lesions be considered. This could be included between an initial antitoxoplasmosis therapy and an invasive procedure such as stereotactic brain biopsy [27] . The finding of CSF positivity for EBV, together with a SPECT showing hypermetabolic lesions is likely to be highly indicative of PCNSL and brain biopsy could, therefore, be avoided. When the CSF is negative for EBV and the SPECT shows hypometabolic lesions, or when only one of the two investigations suggests PCNSL, we would suggest that a brain biopsy be performed [15, 27, 38] .
Wider studies and new protocols, such as the one of the University of Miami [15] , validated by pathologic findings as the gold-standard tool or by response to whole-brain RT [28] , are needed to confirm these promising data and to assess whether these non-invasive techniques should be the first choice for distinguishing between toxoplasmosis and PCNSL in HIV-infected individuals.
Any technique that yields earlier diagnosis carries the advantage of also allowing earlier delivery of appropriate therapy in cases of PCNSL and of encouraging persistence with antitoxoplasmosis chemotherapy in others [22] ,
Even though it appears that whole-brain irradiation is rarely curative in HIV-related PCNSL [44] , and combined-modality treatment with chemotherapy must still be considered investigational [44] , any non-invasive procedure allowing earlier diagnosis of this disease would of course render possible earlier treatment and thus help improve the patient's subsequent quality of life and survival.
We believe that the algorithm we followed is the most reliable method for diagnosing PCNSL; it also serves as a demonstration of the resources offered by a multidisciplinary approach as well as a model for future attempts in other neoplastic disorders.
